Osmotica to Present at 10th Annual SVB Leerink Global Healthcare Conference
February 18 2021 - 4:30PM
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the
“Company”), a fully integrated biopharmaceutical company, announced
today that Brian Markison, Chief Executive Officer, and Andrew
Einhorn, Chief Financial Officer, will present at the 10th Annual
SVB Leerink Global Healthcare Conference as follows:
Date: |
Wednesday, February 24,
2021 |
Time: |
9:20 a.m. Eastern Time |
Webcast: |
https://wsw.com/webcast/svbleerink47/osmt/2693120 |
About Osmotica Pharmaceuticals plcOsmotica
Pharmaceuticals plc (Nasdaq: OSMT) is a fully integrated
biopharmaceutical company focused on the development and
commercialization of specialty products that target markets with
underserved patient populations. The company has a diverse
portfolio consisting of promoted and non-promoted products, several
of which incorporate Osmotica’s proprietary Osmodex® drug delivery
system. RVL Pharmaceuticals, Inc. is the Company’s ophthalmic
subsidiary supporting Upneeq. Vertical Pharmaceuticals, LLC
represents the Company’s diversified branded portfolio and Trigen
Laboratories, LLC represents the Company’s non-promoted products,
including complex generic formulations. Osmotica has operations in
the United States, Argentina, and Hungary.
Investor and Media Relations for Osmotica
Pharmaceuticals plc Lisa M. WilsonIn-Site Communications,
Inc.T: 212-452-2793E: lwilson@insitecony.com
Osmotica Pharmaceuticals (NASDAQ:OSMT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Osmotica Pharmaceuticals (NASDAQ:OSMT)
Historical Stock Chart
From Sep 2023 to Sep 2024